Talkspace(US:TALK)2025-10-30 12:30Financial Performance - Revenue for Q3 2025 is reported at $64 million, with Payor contributing 54% and DTE contributing 34%[6] - The company achieved a +111% YoY growth in Adjusted EBITDA in Q3 2025 and a LTM Adjusted EBITDA of approximately $119 million, compared to approximately $40 million a year ago[17] - Approximately $9 million of shares were repurchased in Q3 under the company's buyback plan[17] Business Growth & Innovation - Unique Active Payor Members increased by +29% YoY, and Payor sessions increased by +37% YoY[16] - Initial psychiatry sessions experienced a +46% sequential growth[16] - Payor Revenue increased by +42% YoY, and Total Revenue increased by +25% YoY[17] - The company broadened its comprehensive care platform with the acquisition of Wisdo Health[16] - Product platform enhancements led to a +50% increase in clients attending the 3rd session in 30 days[16] Partnerships & Brand Awareness - Brand awareness increased, with over 35% of people now recognizing the company[17] Financial Guidance - The company narrowed its 2025 Revenue guidance to $226 million to $230 million, representing a +20% to +23% YoY increase[23] - The company narrowed its 2025 Adjusted EBITDA guidance to $14 million to $16 million, representing a +101% to +130% YoY increase[23]